Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds AAPGV.
No tracked institution reports a position in AAPGV as of their last filing.
No one on the platform has traded AAPGV yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| AAPGVAscentage Pharma Group International | $17.38 | +0.75% | $127M | — |
| ATYRaTyr Pharma, Inc. | $0.55 | +2.35% | $54M | — |
| BCYPBig Cypress Acquisition Corp. | $8.44 | -19.23% | $425M | — |
| CYTCyteir Therapeutics, Inc. | $3.02 | -2.27% | $109M | — |
| DBTXDecibel Therapeutics, Inc. | $4.91 | -0.81% | $123M | — |
| GRAYGraybug Vision, Inc. | $5.50 | -10.80% | $121M | — |
| KNTEKinnate Biopharma Inc. | $2.65 | -0.38% | $125M | — |
Source: Financial Modeling Prep · peers by sector/industry